Work

P-131 Daratumumab (dara) as maintenance therapy after autologous stem cell transplantation (ASCT) in patients with multiple myeloma (MM): results of a phase 2 study

Year: 2023

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(23)01749-4

Authors: Azra Borogovac, Flavia Pichiorri, Jeffrey Matous, Jesus Berdeja, Alexander Pozhitkov, Theophilus Tandoh, Arnab Chowdhury, James Sanchez, Joycelynne Palmer, Ann Morales, Jonathan Keats, Scott Goldsmith, Myo Htut, Murali Janakiram, Nitya Nathwani, Michael Rosenzweig, Amrita Krishnan

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4387026996

Cites:

Cited by:

Related to: 10